Producers, governments and other participants in the global supply chain of molybdenum-99 must act to address an unstable economic structure that is threatening long-term security of supply of the vital medical radioisotope, the OECD Nuclear Energy Agency has warned.

Dutch lawmakers have outlined the requirements for any new nuclear plants with the goal of approving one before 2015.

The global shortage of medical isotopes is coming to an end after the restart of the High Flux Reactor (HFR) at Petten in the Netherlands.